Equipoise (boldenone undecylenate) appears to be comparable to nandrolone in its potency. It lacks nandrolone’s advantage of being metabolically deactivated by 5a -reductase. It is only slightly estrogenic, and only after conversion to estrogen. I cannot at the moment comment on whether the effect it does produce is owed to strong binding at the androgen receptor (AR) or to effectiveness in promoting non-AR-mediated mechanisms for growth.
I wouldn’t expect much results with less than 400 mg/of Equipoise per week. With that dose I would expect to see some noticeable but not dramatic results by the third week. Below 200 mg/week I would expect to see essentially nothing.
Boldenone undecylenate is the chemical name of active ingredient in Equipoise. Equipoise is a registered trademark of Wyeth Holdings Corporation in the United States and/or other countries.
